Real-world comparison of time to next treatment for patients with high-risk CLL/SLL in first line of treatment

被引：0
|
作者：
Hou, Jing-Zhou
Li, John
Vasudevan, Anupama
Gart, Mike
Choksi, Rushir J.
Blanc, Simon
机构：
[1] Univ Pittsburgh Med Ctr UPMC, Pittsburgh, PA USA
[2] Integra Connect PrecisionQ, W Palm Beach, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19027
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Trial in Progress: Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL (REAL)
    Danilov, Alexey
    Farber, Charles
    Boccia, Ralph
    Hrom, John
    Patel, Kamal
    Youssef, Emile
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S9 - S10
  • [42] Real-world Outcomes of Chinese patients with high-risk Multiple Myeloma
    Sui Weiwei
    Deng, Shuhui
    An, Gang
    Xu, Yan
    Hao, Mu
    Mao, Xuehan
    Zou, De-Hui
    Qiu, Lugui
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E222 - E222
  • [43] Chronic lymphocytic Leukemia (CLL) Ibrutinib in the First Line: Standard for High-risk Patients
    Pickl, Susanne
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (1-2) : 76 - 76
  • [44] Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US
    Marrett, Elizabeth
    Zhao, Changgeng
    Zhang, Ning Jackie
    Zhang, Qiaoyi
    Ramey, Dena R.
    Tomassini, Joanne E.
    Tershakovec, Andrew M.
    Neff, David R.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 237 - 246
  • [45] Thrombolysis in high-risk patients with acute pulmonary embolism: underuse of a life-saving treatment in the real-world setting
    Galie, Nazzareno
    Manes, Alessandra
    Dardi, Fabio
    Palazzini, Massimiliano
    EUROPEAN HEART JOURNAL, 2020, 41 (04) : 530 - +
  • [46] OSCAR Study lessons - "EpidemiOlogy and treatment of high-riSk patients in real-world ClinicAl pRactice, 2005-2006"
    Shalnova, S. A.
    Deev, A. D.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (01): : 47 - 53
  • [47] Real-world treatment patterns for patients with high-risk biochemically recurrent nonmetastatic castration-sensitive prostate cancer
    Freedland, Stephen J.
    Ribbands, Amanda
    Butcher, Jake
    Brown, Tom
    Russell, David
    Bland, Christopher S.
    Touya, Maelys
    Ivanova, Jasmina I.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 299 - 299
  • [48] Combination therapy is preferred for the first-line treatment of hypertension in high-risk patients
    Drugs & Therapy Perspectives, 2010, 26 (7) : 17 - 20
  • [49] Impact of Real-World Treatment Sequencing Patterns on Time to Next Treatment among Patients with Chronic Lymphocytic Leukemia in the United States
    Chanan-Khan, Asher Alban
    Challagulla, Swetha
    Kaushiva, Alpana
    Miller, Vincent
    Wang, Yuexi
    Smith, Helen
    Yang, Keri
    BLOOD, 2023, 142
  • [50] POMALIDOMIDE OR CARFILZOMIB USE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: REAL-WORLD TREATMENT PATTERNS, TIME TO NEXT TREATMENT, AND ECONOMIC OUTCOMES
    Parikh, K.
    Purnomo, L.
    Abouzaid, S.
    Chen, C. C.
    McGuiness, C.
    Hussein, M.
    Wade, R.
    HAEMATOLOGICA, 2016, 101 : 603 - 603
12345